Progression-free survival benefit or health-related quality-of-life advantage: which one to choose?

Comment

Cengiz Gemici. J Clin Oncol. 2013.

. 2013 Jul 10;31(20):2635-6.

doi: 10.1200/JCO.2013.49.3478. Epub 2013 Jun 3.

No abstract available

Comment in

Reply to M.C. Chamberlain and C. Gemici.
Soffietti R. Soffietti R. J Clin Oncol. 2013 Jul 10;31(20):2636-7. doi: 10.1200/JCO.2013.49.4443. J Clin Oncol. 2013. PMID: 23991432 No abstract available.

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A. Soffietti R, et al. J Clin Oncol. 2013 Jan 1;31(1):65-72. doi: 10.1200/JCO.2011.41.0639. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213105 Clinical Trial.